Duration of Enoxaparin Bridging
Bridging with enoxaparin typically lasts 5-7 days preoperatively and is resumed postoperatively for at least 24 hours (low-to-moderate bleed risk) or 48-72 hours (high bleed risk) until therapeutic oral anticoagulation is achieved.
Preoperative Bridging Duration
When bridging patients off warfarin for surgery, the standard approach involves:
- Stop warfarin 5 days before surgery to allow INR normalization 1
- Start therapeutic-dose LMWH (enoxaparin 1 mg/kg twice daily or 1.5 mg/kg daily) approximately 3 days before surgery in high thrombotic risk patients 1
- Give last preoperative dose 24 hours before surgery at half the total daily dose (morning of day before surgery), rather than 10-12 hours before, to minimize residual anticoagulant effect at the time of surgery 1
This preoperative window of approximately 3-5 days of bridging allows adequate anticoagulation while warfarin effect wanes.
Postoperative Bridging Duration
The postoperative duration depends critically on bleeding risk:
Low-to-Moderate Bleed Risk Procedures
- Resume LMWH at least 24 hours after surgery once hemostasis is established 1
- Continue until therapeutic INR (2.0-3.0) is achieved, typically 5-7 days total 2
High Bleed Risk Procedures
- Delay LMWH resumption for 48-72 hours after surgery 1
- For patients at high VTE risk during this delay, consider low-dose enoxaparin (40 mg daily) for initial 2-3 days before transitioning to therapeutic bridging 1
- Continue therapeutic bridging until INR reaches 2.0-3.0
Total Bridging Duration
The complete bridging course typically spans 5-7 days minimum from when therapeutic anticoagulation is resumed until warfarin reaches therapeutic effect 2. The FDA label specifies that enoxaparin should continue "for a minimum of 5 days and until a therapeutic oral anticoagulant effect has been achieved (INR 2.0 to 3.0)" with an average duration of 7 days in clinical trials 2.
Real-world practice data shows actual bridging duration may extend longer—one study found mean total LMWH duration of 12 days, with 19% of patients requiring >14 days 3. However, this likely reflects suboptimal INR monitoring rather than ideal practice.
Key Clinical Considerations
Common pitfall: Starting warfarin too late postoperatively. Warfarin should be resumed on the evening of surgery (day 0) or day 1 at the patient's usual maintenance dose 1. This allows adequate time for therapeutic effect while bridging continues.
Dosing specifics: Use full therapeutic doses (enoxaparin 1 mg/kg every 12 hours or 1.5 mg/kg daily) for bridging in high thrombotic risk patients 1, 2. The last preoperative dose should be half the total daily dose given 24 hours before surgery 1.
Special populations: In mechanical heart valve patients or those with recent VTE (<3 months), bridging is more commonly indicated and the same duration principles apply 4, 1.